Serum vitamin-E levels and its relation to clinical features in nonalcoholic fatty liver disease with elevated ALT levels

Acta Gastro-Enterologica Belgica

Volumn 69, Issue 1, 2006, Pages 5-11

  Cankurtaran, Mustafa ^a,b   Kav, T ^a   Yavuz, B ^a   Shorbagi, A ^a   Halil, M ^a   Coskun, T ^a   Arslan, S ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Department of Pediatrics ^*  (Turkey)

Author keywords

Nonalcoholic fatty liver disease; Oxidative stress; Vitamin E

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA TOCOPHEROL; APOLIPOPROTEIN A; APOLIPOPROTEIN B; ASPARTATE AMINOTRANSFERASE; C PEPTIDE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; OXYGEN RADICAL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALPHA TOCOPHEROL DEFICIENCY; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL FEATURE; DISEASE COURSE; ECHOGRAPHY; FAMILY HISTORY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIVER BLOOD FLOW; LIVER FUNCTION TEST; LIVER SIZE; LOW CALORY DIET; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PROPHYLAXIS; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WAIST HIP RATIO;

EID: 33645675566     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. FALCK-YTTER Y., YOUNOSSI Z.M., MARCHESINI G., MC CULLOUGH A.J. Clinical features and natural history of NASH. Semin. Liver Dis., 2001, 21 (1): 17-26.
2. DAY C.P., JAMES O.F. Steatohepatitis: a tale of two "hits"? Gastroenterology, 1998, 114: 842-845.
3. MEHTA K., VAN THIEL D.H., SHAH N., MOBARHAN S. Nonalcoholic tatty liver disease: pathogenesis and the role of antioxidants. Nutr. Rev., 2002 Sep, 60 (9): 289-93.
4. KUMAR K.S., MALET P.F. Nonalcoholic Steatohepatitis. Mayo Clin. Proc., 2000, 75: 733-739.
5. RICCARDI G., RIVELLESE A. Dietary treatment of the metabolic syndrome-thye optimal diet. British J. of Nutr., 2000, 83 (1): 143-148.
6. STRAUSS R. Comparison of serum concentration of vitamin-E and carotene in a cross sectional sample of obese and nonobese children. J. Pediatr., 1999, 134: 160-165.
7. PFLUGER P., KLUTH D., LANDES N., BUMKE-VOGT C., BRIGELIUS-FLOHE R. Vitamin E: underestimated as an antioxidant. Redox. Rep., 2004, 9 (5): 249-54.
8. ZINGG J.M., AZZI A. Non-antioxidant activities of vitamin E. Curr. Med. Chem., 2004 May, 11 (9): 1113-33.
9. DUFOUR J.F. Vitamin-E and antioxidants in treatment of NASH. Falk Symposium 121. October, 2000.
10. KUGELMAS M., HILL D.B., VIVIAN B., MARSANO L., MC CLAIN C.J. Cytokines and NASH: A Pilot Study of the Effects of Lifestyle Modification and Vitamin E. Hepatology, 2003, 38 (2): 413-419.
11. LAVINE J.E. Vitamin E treatment of nonalcoholic steatohepatitis in children. The J. Pediatr., 2000, 136 (6): 734-738.
12. ANGULO P., LINDOR K. Treatment of Nonalcoholic fatty liver disease: Present and emerging therapies. Seminars in Liver Dis., 2001, 21 (1): 81-88.
13. HASEGAWA T., YONEDA M., NAKAMURA K., MAKINO I. Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: A pilot study. Aliment Pharmacol. Ther., 2001, 15: 1667-72.
14. HARRISON S.A., WARD J.A., SCHENKER S. The role vitamin E and C therapy in NASH. Am. J. Gastroenterol., 2004, 99 (9): 1862.
15. HARRISON S.A., TORGERSON S., HAYASHI P., WARD J., SCHENKER S. Vitamin E and Vitamin C Treatment Improves Fibrosis in Patients With Nonalcoholic Steatohepatitis. Am. J. Gastroenterol., 2003, 98 (11): 2485-2490.
16. YONEDA M., HASEGAWA T., NAKAMURA K., TAMANO M., KONO T., TERANO A. Vitamin E Therapy in Patients With NASH. Hepatology, 2004, 39 (2): 568-569.
17. GEORGE D.K., GOLDWURM S., MCDONALD G.A., COWLEY L.L., WALKER N.I., WARD P.J., JAZWINSKA E.C., POWELL L.W. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology, 1998, 114: 311-318.
18. DESWERGENE B., WAHLI W. Peroxisome proliferator activated receptors: nuclear control of metabolism. Endocr. Rev., 1999, 20: 649-688.
19. SAMBASIVA M., JANARDAN K. Peroxisomal b-oxidation and steatohepatitis. Seminars in Liver Dis., 2001, 21 (1): 43-55.
20. COATES R.A., HALLIDAY M.L., RANKIN J.G., FEINMAN S.V., FISHER M.M. Risk of fatty liver infiltration of cirrhosis of the liver in relation to ethanol consumption: a case-control study. Clin. Invest. Med., 1986, 9: 26-32.
21. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 2001, 285: 2508-2509.
22. BELMER S., BUBNOVA L., KALINTZEVA V., GASSILINA T. Steatohepatits in Coeliac disease children. Falk Symposium 121 "Steatohepatitis", 2000, p. 4.
23. LETTERON P., FROMENTY B., TERRIS B., DEGOTT C., PESSAYRE D. Acute and chronic steatosis lead to in vivo lipid peroxidation in mice. J. Hepatol., 1996, 24: 200-208.
24. CHITTURI S., FARRELL G.C. Etiopathogenesis of Nonalcoholic Steatohepatitis. Seminars in Liver Dis., 2001, 21 (1): 27-41.
25. YNGVE F.Y., YOUNOSSI M.Z., MARCHESINI G., MCCULLOUGH J.A. Clinical features and natural history of Nonalcoholic steatosis syndromes. Seminars in Liver Dis., 2001, 21 (1): 17-26.
26. SCHUTTE A.E., HUISMAN H.W., OOSTHUIZEN W., VAN ROOYEN J.M., JERLING J.C. Cardiovascular effects of oral Supplementation of vitamin C, E and folic acid in young healthy males. Int. J. Vitam. Nutr. Res., 2004 Jul, 74 (4): 285-93.
27. EIDELMAN R.S., HOLLAR D., HEBERT P.R., LAMAS G.A., HENNEKENS C.H. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch. Intern. Med., 2004 Jul 26, 164 (14): 1552-6.
28. POLIDORI M.C., MATTIOLI P., ALDRED S., CECCHETTI R., STAHL W., GRIFFITHS H., SENIN U., SIES H., MECOCCI P. Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia. Dement. Geriatr. Cogn. Disord., 2004, 18 (3-4): 265-70. Epuh 2004 Jul 29.
29. HAK A.E., MA J., POWELL C.B., CAMPOS H., GAZIANO J.M., WILLETT W.C., STAMPFER M.J. Prospective study of plasma carotenoids and tocopherols in relation to risk of ischemic stroke. Stroke. 2004 Jul, 35 (7): 1584-8. Epub 2004 Jun 03.
30. VOKO Z., HOLLANDER M., HOFMAN A., KOUDSTAAL P.J., BRETELER M.M. Dietary antioxidants and the risk of ischemic stroke: the Rotterdam Study. Neurology, 2003 Nov 11, 61 (9): 1273-5.
31. MORRIS M.C., EVANS D.A., TANGNEY C.C., BIENIAS J.L., WILSON R.S., AGGARWAL N.T., SCHERR P.A. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am. J. Clin. Nutr., 2005 Feb, 81 (2): 508-14.
32. MATTEONI C., YOUNOSSI M.Z., GRAMLICH T., BOPARAI N., LIU Y.C., MCCULLOUGH A.J. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology, 1999, 116: 1413-1419.
33. ADAMS L.A., ANGULO P. Vitamins E and C for the Treatment of NASH: Duplication of Results but Lack of Demonstration of Efficacy. Am. J. Gastroenterol., 2003 Nov, 98 (11): 2348-2350.